3-5
2026
影响因子区间
—
平台估算
47%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect.These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.
【译文】每月,该期刊发布研究人员使用各种最新技术获得的易于吸收的最新实验发现报告。鼓励促进全球细胞生物学家的目标,特别是那些与整个细胞的生理学相关的研究结构和功能的论文。只要文章报告的发现能够在细胞生物学的更广泛背景下看到,分子生物学也是受欢迎的。在涵盖细胞的所有领域时,该期刊对广泛的受众既有吸引力又易于接近。对于那些论文主题过于专业化(例如,感染微生物,原生动物学)而无法吸引一般细胞生物学家的作者,建议他们将其发送到更相关的期刊。报告整个动物研究或更适合医学期刊的工作,例如组织病理学或临床免疫学,不太可能被接受,除非它们完全关注某些重要的细胞方面。这些最后的话尤其适用于关于癌症的论文。除非基于某些更深入的细胞或分子生物学原理,否则在这个领域高度专业化、对广大细胞生物学家吸引力有限的论文,应指导向致力于癌症的期刊投稿,因为可供选择的选择非常多。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |